Thus, the ratio of Bax/Bcl‐2, as candidate prognostic biomarkers for lung cancer, indicates the degree of mitochondrial outer membrane permeabilization and hence the entrance to the execution phase of the apoptotic program 21. This evidence concerns the gene BCL2 and lung cancer.